to soluble guanylyl cyclase, the target of CO action. To examine the generation of CO by neurons, we measured CO production directly and determined its relationship to cyclic GMP levels in cultured rat olfactory receptor neurons. This system has the advantage of not having measurable NO production, which could confound results since NO is a more potent activator of guanylyl cyclase than CO. Metabolic labeling experiments permitted the direct measurement of %O production by neurons in vitro. CO release parallels endogenous cyclic GMP concentrations with its peak at the immature stage of neuronal differentiation in culture. Cyclic GMP production is inhibited by zinc protoporphyrin-9 and zinc deuteroporphyrin IX 2,4-bis glycol, inhibitors of heme oxygenase, indicating that CO is an endogenous regulator of soluble guanylyl cyclase activities in these cells. Transforming growth factor-p2, an olfactory neurogenic factor, specifically shows a negative effect on CO release in olfactory receptor neurons.
These results indicate that CO may serve as a gaseous neuronal messenger linked to cyclic GMP production and suggests its involvement in developmental processes of the olfactory receptor neuron. [Key words: heme oxygenase, carbon monoxide, cyclic GMP, second messenger, olfaction, transforming growth factor-p] Wang, 1993; Zhuo et al., 1993) . Like NO, CO can bind to the iron in heme and activate guanylyl cyclase (Brune and Ullrich, 1987; Graser et al., 1990; Furchgott and Jothianandan, 1991) . Heme oxygenase (HO), which degrades heme to biliverdin and in the process releases CO (Maines, 1988; Marks et al., 1991; Schmidt, 1992) consists of two homologous isozymes. While type 1 (HO-l) is induced by heme and is most abundant in the spleen and in other peripheral tissues, type 2 (HO-2) is the constitutive form which is expressed at high levels in the brain (Cruse and Maines, 1988; Maines, 1988; Sun et al., 1990) . By in situ hybridization and immunohistochemistry, discrete neuronal localization of HO-2 throughout the brain has been demonstrated (Ewing and Maines, 1992; Verma et al., 1993) . In fact, the localization of HO-2 by in situ hybridization more closely overlaps the localization of soluble guanylyl cyclase than does the localization of nitric oxide synthase (NOS) (Verma et al., 1993) . In addition to HO-2, the enzymes responsible for heme biosynthesis and degradation, during which CO is released, have recently been identified in the brain (Verma et al., 1993) .
Several studies have implicated CO in various physiological functions. Like NO, CO has been implicated as a candidate retrograde messenger for long-term potentiation (LTP) since the HO inhibitors, zinc protoporphyrin-9 (ZnPP-9) and zinc deuteroporphyrin IX 2,4-bis glycol (ZnBG) block the induction of LTP in hippocampal slices (Stevens and Wang, 1993; Zhuo et al., 1993) . Additionally, long-lasting increases in amplitudes of evoked potentials are seen when CO is applied concomitantly with weak tetanic stimulation (Zhuo et al., 1993) . The chemosensors of the carotid body may also be affected by CO. These chemosensors are activated by molecular oxygen and inhibited by CO (Gonzalez et al., 1992) . It has recently been demonstrated that the carotid body has high levels of HO-2 immunoreactivity, and ZnPP-9 markedly enhances chemosensory discharges in the carotid body (Prabhakar et al., 1995) . Other investigators (Meffert et al., 1994) however, have failed to demonstrate a role for co.
Within this controversy is the fact that direct evidence for the physiological generation of CO by neurons is lacking. Furthermore, CO would need to be produced at significant enough concentrations so as to affect soluble guanylyl cyclase activity. In vitro studies demonstrate that NO is at least 30-fold more potent at activating soluble guanylyl cyclase than CO (Stone and Marletta, 1994) . Thus, in cell systems expressing both HO and NOS, it may be difficult to assess the role of CO. An in vitro neuronal cell system expressing high levels of HO activity but in which NOS activity is essentially absent, would be useful in assessing the physiological generation of CO and its function.
We have selected the olfactory receptor neuron as a model to examine the role of CO production by neurons for several reasons. First, recent evidence suggests that olfactory receptor neurons have a high level of expression of HO-2 but lack NOS activity (Verma et al., 1993) , which provides us with an ideal model in which to detect the amount of' physiological CO production and to explore its effect on guanylyl cyclase activity. Second, high levels of heme-synthesizing enzymes are expressed in the olfactory receptor neuron (Verma et al., 1993) . This suggests that olfactory receptor neurons possess a source for endogenous production of CO. In addition, the olfactory epitheliurn is an excellent model for the study of neuronal differentiation. It is unique in the adult mammalian nervous system in that it is a site of ongoing neurogenesis (Graziadei and Graziadei. 1978) . Recently, studies have used the development of the olfactory epithelium as a model to demonstrate that NO is transiently expressed during olfactory receptor neuron development (Bredt and Snyder, 1994; Roskams et al., 1994) . Since neuronal NOS is absent from the adult system (Roskams et al., 1994) , it may be that another messenger such as CO is important in olfactory receptor neuronal maturation. Recent studies have demonstrated that neurogenesis can take place in cultures of olfactory cpithelium (Calof and Chikaraishi, 1989; Pixley, 1992) , and it has been observed that interplay between several pcptide growth factors modulate the proliferation and differentiation of olfactory epithelium cells (Mahanthappa and Schwarting, 1993; DeHamer et al., 1994) . Transforming growth factor-P2 (TGFp2) is known to be a neurogenic factor which initiates terminal maturation of olfactory receptor neurons (Mahanthappa and Schwarting, 1993) . In this study we utilize '-'C-glycine to metabolically label endogenous heme and directly measure the physiological production of CO by these olfactory receptor neuronal cultures. We then go on to investigate the role of CO in cyclic GMP (cGMP) regulation during the maturation of' these olfactory receptor neurons in culture. preimmune serum or affinity-purified antibody preabsorbed with the appropriate antigen, showed no staining using identical incubation and development conditions (data not shown).
Material and Methods
'"CO m4usurement, Primary cultures of ollactory receptor neurons were prepared l'rom neonatal rats as previously described (Ronnett et al., IO9 I), and cultured in slide flasks at a density of 1 X 10h cells per cm'. These cultures contained less than I % glial contaminants (Konnett et al.. 199 I) . On each culture day, slide flasks were preincubated with 5 p,Ci 2m11C-glycine for 5 hr, and then the radioactivity incorporated into laCO was measured as described (Lincoln et al., 19X9) . Briefly, the gases from cultured flasks were drawn through the following series of traps: ethanolamine-methanol (trap for CO,), HISO,,, CaCl?, heated hopcalite, and ethanolamine-methanol (trap for CO). '-'CO was converted to "CO? by hopcalite and collected in the second ethanolamine-methanol trap. Each trapping solution was counted. The proportion of r-eleased "CO compared to "CO, ranged from 2 to 17%. No radioactivity over background (30 cpm) was detected in the CO trap when hopcalite was removed from the series of traps. When inhibitors were used, culL tures were incubated with '"C-glycine in the presence of ZnPP-9, ZnBG, or nitroarginine methyl ester (NAME) at the indicated concentrations for 5 hr. after which time the gases were drawn from the flasks. In the growth factor experiment, primary cultures of neonatal rat olfactory receptor neurons were plated as described previously, except that the cells were plated in a medium which did not contain exogenous growth factor-s. Approximately 6 hr after cell plating, the feeding medium was I-eplaccd with fresh medium containing 10 rig/ml of the peptide growth factors. Cultures were maintained for I-S d, at which time lJCO production was measured as previously described to determine the effect 01. each peptide growth factor. For dose-response curves, cultures were treated similarly on day 3, except that varying concentrations of were added to the cultures, Combination with SO rig/ml antinerve growth factor (anti-NGF) was also tried to get rid of any endog enous NGF effect; however, no significant change was observed (data not shown). is localized to essentially identical structures, including the olfactory receptor neuron cell layer (ORN), the ciliary layer (CL), and axon bundles (Ax). In addition, striking immunoreactivity is seen in dendritic processes (0) and at all levels of olfactory receptor neuron maturity. Round vacuolarlike structures represent blood vessels cut in cross section. Olfactory bulbectomies cause retrograde degeneration of olfactory receptor neurons. Staining was performed 3 d after bulbectomy to demonstrate that when olfactory receptor neurons degenerate and are removed from the epithelium; immunoreactivity for HO-2 (C) and soluble guanylyl cyclase (D) is absent, confirming their localization to olfactory receptor neurons.
cGMP was assayed. Control concentrations of cGMP in this experiment were 23 pmoVmg of protein, which is relatively high due to the IBMX treatment.
Reverse transcriptase-polymerase chain reaction (RT-PCR). Primary cultures of olfactory receptor neurons were maintained in a feeding medium with/without 10 rig/ml TGF-P2. On day 3, poly(A) RNA was prepared from cultured olfactory receptor neurons. cDNA was synthesized in a 50 p,l reaction utilizing 1 pg of poly(A) RNA. The-RNA mixed with 100 ng oligo(dT) primer was denatured for 10 min at 70°C and cooled to 37°C. Reverse transcription was performed at 37°C for 1 hr after addition of 10 ~1 of 5 X reverse transcription buffer (BRL), 5 p,l of 0.1 M DTT, 2 pl of 2.5 mM dNTPs, 20 U of RNasin, 2 p.1 of MMLV reverse transcriptase (Superscript, BRL). After first-strand cDNA synthesis, HO-2 and p-actin PCR products were generated from these cDNA's; 5 yl of cDNA was utilized as template in subsequent 50 ~1 PCRs. PCR amplifications were performed 30 cycles with following specific oligo primers (0.5 PM); P16 and P17 for HO-2, Act-5 and Act-3 for p-actin. Under the condition used, PCR products increased linear bqtween 28-33 cycles. Oligonucleotides used as PCR primers were synthesized from the following positions in the cDNAs. HO-2 : P16 = 5'-CACTTGGGATAGGATGCAAACAAC-3' (984-961 on cDNA), P17 = 5'-mGAATGAGCCAAGGACCGAAGTG-3'
(-49 to -25 on cDNA). Predicted size of PCR products with P16 and 617 is 1033 bp. B-Actin [Nude1 et al.. 1983) : Act-5 = 5'-ATGGATGACGATATCG-?ZTGCGdTC-3' (124211265 'on gene), Act-3 = 5'-GGCCAGGATAG-AGCCACCAATCCA-3'
(3045-3022 on gene). Predicted size of PCR products with Act-5 and Act-3 is 1042 bp.
Results
Colocalization of HO-2 and soluble guanylyl cyclase immunoreactivities in the adult olfactory neuroepithelium A necessary prerequisite for a functional role of HO as a mediator of guanylyl cyclase activity is the expression of these proteins in olfactory receptor neurons. For this reason, immunohistochemistry was performed using affinity-purified anti-peptide antibodies directed against rat HO-2 and the p, subunit of rat soluble guanylyl cyclase. HO-2 immunoreactivity was detected in the olfactory receptor neuron of the adult olfactory neuroepithelium (Fig. 1A) . Immunoreactivity was seen in the cilia1 layer in the pseudostratified layer of olfactory receptor neuron cell bodies, and in the axon bundles in the submucosal region. No staining was apparent in the sustentacular cell layer located superficially in the neuroepithelium. In addition, there was no immunoreactivity in the most basally located cells, which represent the most immature olfactory receptor neurons. Soluble guanylyl cyclase immunoreactivity has nearly an identical pattern (Fig. 1B) . In this case, immunoreactivity was seen in the cilia1 layer, in the olfactory receptor neuron cell body layer, and in axon bundles. Immunoreactivity was also seen prominently in dendritic processes. A subtle difference exists between the . CO production in primary cultures of olfactory receptor neurons. Primary cultures of olfactory receptor neurons were prepared as described and used for r4C0 release from 1 to 5 d in culture. On each culture day, cultures in slide flasks were preincubated with 5 pCi 2-14C-glycine for 5 hr and the radioactivity incorporated into YO was measured. A, Time course of CO production in rat olfactory receptor neurons in culture. 'CO production changes dramatically in culture, peaking during the time of neurite outgrowth, although 14C0, production is constant every culture day (data not shown).bata are presented as the mean of4-10 independent experimental determinations ? SBM. B, Effect of inhibitors on CO production in primary cultures of olfactory receptor neurons on day 3. 'CO production is inhibited by ZnPP-9, but unaffected by NAME. ZnBG inhibited 14C0 production in a manner similar to that of ZnPP-9 (1 p,~ ZnBG inhibited "CO production to 41 ? 3.2% of control).
immunolocalizations for HO-2 and soluble guanylyl cyclase in that soluble guanylyl cyclase immunoreactivity was observed extending down to olfactory receptor neurons and to precursor cells at the basal lamina. Ablation of the olfactory bulb results in retrograde degeneration of the olfactory receptor neurons over a 1 week period (Margolis et al., 1974) . Large vacuoles develop in the regions of axon bundles. As olfactory receptor neurons degenerate, neuronal markers normally associated with olfactory receptor neurons disappear from the neuroepithelium. Three days after bulbectomy, HO-2 immunoreactivity (Fig. 1C) and soluble guanylyl cyclase immunoreactivity (Fig. 1D) significantly decreased, further confirming their localization to olfactory receptor neurons. Residual staining in the olfactory receptor neuronal layer represents olfactory receptor neuronal cell bodies which have not yet degenerated by three days after bulbectomy. Thus, HO-2 is appropriately located to affect soluble guanylyl cyclase activity.
CO production by olfactory receptor neurons To investigate the generation of CO by neurons, primary cultures of olfactory receptor neurons were used. In addition to HO-2, olfactory receptor neurons contain a high density of heme-metabolizing enzymes such as &aminolevulinate synthase (ALAS) and cytochrome P-450 reductase (CPR) (Verma et al., 1993) . Since the colocalization of ALAS with HO-2 in the receptor neurons indicates that the machinery for porphyrin turnover and CO biosynthesis occur together (Verma et al., 1993) , olfactory receptor neurons were incubated with 2-Y-glycine, a heme precursor, to label CO produced by HO-2. Five hours after the addition of 'C-glycine, "CO resulting from heme metabolism was measured in these cell cultures (Landaw and Winchell, 1966; Lincoln et al., 1989) . As shown in Figure 2A , there is a sharp increase of YO release, from 0.41 -C 0.07 pmol/mg protein at day 1 in culture, to 2.0 + 0.16 pmoVmg protein at day 3.
To determine the total amount of CO production, cellular uptake of 14C-glycine was measured in cultures. Under the condition used, cellular uptake of 14C-glycine remained linear for 5 hr and the average concentration of Y-glycine for this period in the cells was determined to be 380 pmol/mg protein. Taking into account the ratio of Y-glycine to the total endogenous glycine levels in neuronal cells (20 nmoVmg protein) (Hall et al., 1979; Freeman et al., 1983) , the total amount of CO production from glycine at day 3 is estimated to be approximately 100 pmol/mg protein. Afterwards 'CO release falls rapidly and returns to the previous levels by days 4 and 5. This peak in 14C0 production parallels the time during which neurite extension is occurring in culture (Ronnett et al., 1991) . The level of HO activity in olfactory receptor neurons is the highest when it is compared to those of other brain regions (Verma et al., 1993) , making the production of CO by olfactory receptor neurons robust. In contrast, 14C-carbon dioxide (YO,) production was constant (data not shown).
To determine the pathway of CO generation, ZnPP-9, a potent inhibitor of HO function, was utilized (Maines, 1981; Stevens and Wang, 1993) . ZnPP-9 lowered "CO release, with half-maximal inhibition occurring at 0.2 pM ZnPP-9 (Fig. 2B) . ZnBG, another potent inhibitor of HO (Schuman and Madison, 1991b; Vreman et al., 1991) , inhibited 'CO production in a manner similar to that of ZnPP-9 (1 FM ZnBG inhibited 'CO production to 41 ? 3.2% of control). These results indicate that 14C0 is generated predominantly from heme breakdown by HO in the olfactory receptor neuron, which agrees with the previous finding that HO is the predominant pathway of heme degradation in vivo (Lincoln et al. 1989 ). On the other hand, nitroarginine methyl ester (NAME), a potent inhibitor of NOS, failed to significantly alter 14C0 release, in spite of the similarities between NOS and CPR (Fig. 2B) . Over days 14 in culture, cGMP levels were assayed by radioimmunoassay. A, Time course of endogenous cGMP concentration. cGMP levels change over time, increasing to a maximum at day 2 in culture which parallels CO production and neurite outgrowth. Data are presented as the mean of five to six independent experimental determinations -C SEM. B, Effect of ZnPP-9 and NAME on cGMP concentration over time in culture. ZnPP-9 at a concentration of 1.0 PM significantly lowers cGMP concentrations, whereas 0.1 mM NAME has little effect. C, Dose-response curve of ZnPP-9 effect on cGMP concentrations. ZnBG lowered cGMP concentrations in a manner similar to ZnPP-9 (1 p,M ZnBG lowered cGMP levels to 73.2 -C 2.3% of control). ZnPP-9 and ZnBG lower cGMP levels with the same IC,, as their effect on 14C0 production.
CO regulates cGMP levels in olfactory receptor neurons CO is known to be an activator of soluble guanylyl cyclase (Briine and Ullrich, 1987; Grgser et al., 1990; Furchgott and Jothianandan, 1991) . Recent evidence suggests that CO may function as an endogenous regulator of soluble guanylyl cyclase in the brain (Marks et al., 1991; Maines et al., 1993; Verma et al., 1993) . In contrast to discrepancies in the localizations of NOS and guanylyl cyclase in the brain, guanylyl cyclase localization is virtually identical to that of HO-2 in numerous brain regions (Verma et al., 1993) . Because olfactory receptor neurons contain large concentrations of HO-2 and soluble guanylyl cyclase, we directly determined that CO is a mediator of cGMP production in these cells. To determine whether the CO generated by HO is a physiological messenger in olfactory receptor neurons, cGMP levels and the effects of ZnPP-9 on cGMP 1evCls were monitored over time in olfactory receptor neuron cultures. As shown in Figure  3A , there is an increase of endogenous cGMP from 9.2 ? 0.94 pmol/mg protein level in day 1. After the peak of 17 -C I .9 pmol/mg protein on day 2, cGMP levels fall to their lowest level by day 4. The change in cGMP concentration essentially parallels that of CO release. Furthermore, on each day, 1 PM ZnPP-9 significantly lowers endogenous cGMP, which agrees with its ability to act as an inhibitor of HO activity (Fig. 3B) . A dose-response curve was generated for the inhibitory effect of ZnPP-9 on cGMP levels in these cells (Fig. 3C) . As with the effect of ZnPP-9 on YO release, half-maximal inhibition occurs at a concentration 0.2 FM ZnPP-9. In addition, ZnBG lowered cGMP concentrations in a manner similar to ZnPP-9 (1 PM ZnBG lowered cGMP levels to 73.2 t 2.3% of control). On the other hand, 0.1 mM NAME did not show a significant effect on cGMP levels, also in agreement with its inability to affect CO release (Fig. 2B) . Although there are several assays for NOS activity, the use of NAME to identify an NO-mediated cGMP component is considered to be among the most sensitive. This result of NAME treatment confirms the previous finding that olfactory receptor neurons do not contain detectable levels of NOS (Verma et al., 1993) . In preparations of purified and reconstituted enzymes, studies suggest that HO inhibitors may act at the level of soluble guanylyl cyclase (Ignarro et al., 1984) , which would potentially confound our results. To determine whether these HO inhibitors are acting at the level of guanylyl cyclase, we previously conducted conditioned media transfer experiments with ZnPP-9 (Verma et al., 1993) and now with an additional inhibitor of HO, ZnBG. In media transfer experiments, as shown in Table 1 , recipient cells treated with 1 FM ZnBG had low levels of cGMP (60 -C 1.7% of control). Addition of conditioned media from donor cells to recipient cells treated with ZnBG elevated cGMP levels (88.7 t 3.4%). Thus, ZnBG cannot act at the level of soluble guanylyl cyclase, as donor medium which provides CO can elevate cGMP levels. In addition, when donor cells were preincubated with ZnBG and then the media was transferred to recipient cells treated with ZnBG, cGMP levels remained low (53.9 -+ 5.2%). These results clearly indicate that these HO in- (0) cultures'. Approximately 6 hours-after Eel1 plating, the feeding me&urn was replaced with fresh medium containing no growth factor (control) or 10 &ml NGF to observe effects of NGE There is little effect of NGF on "'CO release. Cultures were maintained for 1-5-d, at which time 14C6 produc;on was measured. Data are presented as the mean of two independent experimental determinations. B, Effect of TGF+2 on CO production (0) compared with control (0) cultures. To observe the effect of TGF-P2, feeding medium was replaced with medium containing 10 ndml TGF432. TGF-R2 treatment results in the suooression of YO release to basal levels. C, Dose-response curve of TGF+2 effect on?0 pr:duction on day 3.
hibitors act on the CO generating cell (the level of HO) but not on the responding cell (the level of guanylyl cyclase). Collectively, these results suggest that CO may be a physiological mediator of the changes in endogenous cGMP levels.
Neuronal maturation induces a change in CO production Olfactory receptor neurons are continually replaced throughout adult life, making them a unique class of neurons (Graziadei and Graziadei, 1978 ) and an excellent model for the study of neuronal differentiation. Several cultured systems of olfactory receptor neurons or olfactory epithelium have been used to study this process in vitro (Calof and Chikaraishi, 1989; Pixley, 1992; Mahanthappa and Schwarting, 1993) . Olfactory neurogenesis is a multistage process which includes the differentiation of basal cells into committed neuronal precursors, precursor proliferation, and differentiation of the precursors into postmitotic neurons (Calof and Chikaraishi, 1989) . Recent studies have demonstrated that TGF-P2 initiates terminal differentiation and promotes neurogenesis or survival in olfactory receptor neurons in culture, while epidermal growth factor (EGF) acts as a mitogen for the basal cell (Mahanthappa and Schwarting, 1993) . In olfactory epithelium cultures, TGFj32 caused an increase in neuron cell adhesion molecule (N-CAM)-positive cells; N-CAM is a marker of olfactory neurogenesis (Calof and Chikaraishi, 1989; Mahanthappa and Schwarting, 1993) . As shown in Figure 2A , CO production changes dramatically during neuronal maturation in culture. In primary cultures, olfactory receptor neurons start to extend neurites at day 1 and a mature neuronal appearance is established by about day 4 (Ronnett et al., 1991) . To investigate whether the CO signaling system may be involved in olfactory neurogenesis, the effects of TGFj32 and NGF on CO release were determined. Primary cultures of olfactory receptor neurons were plated in the presence or absence of 10 rig/ml NGF or 10 rig/ml TGFj32, and YO release was determined for days 1-5. As shown in Figure 4A , there is no significant difference in VO release in the absence or presence of NGE However, in the presence of TGFj32, the usual peak of VO release at day 3 was significantly suppressed (Fig. 4B) . The dose-dependent effect of TGF-62 on YO was determined in the range of 0.01-10 rig/ml on day 3, when the maximal effect of TGF-P2 was seen (Fig. 4C) . As shown in Figure 5 , RT-PCR revealed that TGF-P2 specifically suppresses the expression of messenger RNA of HO-2 in cultures. Taking into account the very slow onset of TGFj32's effect, TGF-62 is likely to modulate CO production by reducing protein expression of HO-2 but not by inhibiting its enzymatic activity. TGFp2 promotes differentiation of olfactory receptor neurons in these cultures at 10 rig/ml concentrations; this growth factor causes increased neurite outgrowth and an increased percentage of differentiated cells (Mahanthappa and Schwarting, 1993) . The negative control of TGF-62 on CO release suggests that the physiologic role of CO production and cGMP production may be at earlier stages in olfactory neuronal development and differentiation.
The effects of various peptide growth factors were examined to determine the effect specificity of TGF+2 on CO release, (Fig. 6) . Messenger RNA for NGF and brain-derived neurotrophic factor (BDNF) have been detected in the olfactory bulb (Guthrie and Gall, 1991) . However, NGF, BDNF, and neurotrophin-3 only minimally lower WO release (Fig. 6) . In contrast to the effects of TGF+2, both EGF and TGF-a stimulate the proliferation of olfactory basal cells in vitro (Mahanthappa and Schwarting, 1993) . EGF and TGF-a show intermediate suppression of YO release (Fig. 6) . Messenger RNA for basic fibroblast growth factor (bFGF) has been detected in the olfactory bulb (Ernfors et al., 1990) and intense immunoreactivity for platelet derived growth factor (PDGF) is seen around the olfactory neuron at all stages of development, from embryo to adult (Sasahara et al., 1992) . Both bFGF and PDGF show intermediate suppression of YO release. However, TGF-P2 showed the highest suppression of "CO among all tested factors. This spec- Figure 5 . Effect of TGF-P2 on HO-2 mRNA in primary cultures of olfactory receptor neurons. Primary cultures of olfactory receptor neurons were maintained in a feeding medium containing no growth factor (control) or 10 rig/ml TGF-P2. RNA was prepared from these 'cultured olfactory receptor neuron on dav 3. RT-PCRs were oerformed using pri'mers specific for ho-2 and p-actin. The level of mRNA of HO-2 in olfactory receptor neurons was significantly suppressed by the effect of TGF-P2: The-predicted sizes of PCR products of HO-2 and p-actin are 1033 bp and 1041 bp each. 
Discussion
The main findings of this study are that olfactory receptor neurons express HO-2 and soluble guanylyl cyclase and that the high levels of CO produced by the action of HO-2 mediate cGMP levels in these cells. Abundant evidence has established a major role for NO, a free radical gas that activates soluble guanylyl cyclase, as a messenger molecule in blood vessels, macrophages, and brain (Moncada et al., 1991) . Although CO -CONDITION Figure 6 . Effects of peptide growth factors on CO production in primary cultures of olfactory receptor neurons. Approximately 6 hr after cell plating, the feeding medium was replaced with fresh medium containing 10 rig/ml of the indicated peptide growth factors. On day 3, 'CO production was measured to determine the effect of each peptide growth factor. Data are presented as the mean of two to four independent experimental determinations. Of all factors tested, TGFj32 demonstrates the largest effect on YO production.
is known to be an activator of soluble guanylyl cyclase like NO, and HO-2 has been localized to discrete brain regions where it colocalizes with soluble guanylyl cyclase, direct demonstration of CO production by neurons has been lacking. Using 14C-glytine to metabolically label heme, it is now directly demonstrated that olfactory receptor neurons in culture are capable of modulating CO production by HO and that this rate of production is high. Brain tissues have long been known to have HO enzymatic activity, which could be measured in the presence of exogenous substrates when assays were performed in vitro. However, this is the first direct demonstration of CO produced physiologically from heme synthesized endogenously by neurons. Although basal levels are quite high, CO production changes dramatically during neuronal maturation in culture and the peak of CO production corresponds to the immature stage of olfactory receptor neuron development in culture. The total amount of CO production from glycine in olfactory receptor neurons was calculated to be approximately 100 pmol/mg protein. This may underestimate the actual CO production since only unbound CO was measured. In fact, olfactory receptor neurons in culture demonstrate considerably higher HO activity, as measured by the production of CO, when compared with primary hepatocyte or cerebellar granule cell cultures (Ingi et al., unpublished data) . Initial interest in CO as a potential physiological messenger arose from a number of experiments which demonstrated that exogenous CO had biological effects similar to that of NO (Brtine and Ullrich, 1987; Marks et al., 1991) . CO is known to inhibit platelet aggregation (Brtine and Ullrich, 1987) and it can produce relaxation in rabbit arterial preparations (Furchgott and Jothianandan, 1991) . These activities were thought to be mediated by an activation of guanylyl cyclase by CO. CO has subsequently been shown to cause increases in cGMP levels in cultured rat aortic smooth muscle cells (Ramos et al., 1989) . Although several sources exist for the endogenous production of CO (Schmidt, 1992) , the principal physiological pathway is by the action of HO which catalyzes the conversion of heme to biliverdin, releasing CO in the process (Lincoln et al., 1989) . Of the two isoforms of HO thus far identified, HO-l is inducible by heme and other agents such as transition and heavy metals; it is expressed at high levels in spleen and liver where its principal function is thought to be heme catabolism. The second isoform, HO-2, is present in several peripheral tissues and in the brain, where it has been demonstrated to have discrete neuronal localization by in situ hybridization and immunohistochemistry. Thus, a large number of observations concerning endogenous production of CO and its potential messenger role have focused on HO and have made use of HO inhibitors to study this process in various cell preparations (Stevens and Wang, 1993; Zhuo et al., 1993; Prabhakar et al., 1995) .
To support a physiological role for CO produced by HO as a mediator of guanylyl cyclase activation, in situ hybridization for HO-2 and soluble guanylyl cyclase demonstrated that these two enzymes colocalize in large degree to discrete neuronal populations in general, overlapping more consistently than the localization of neuronal NOS and guanylyl cyclase (Verma et al., 1993) . The highest concentrations of HO-2 occur in olfactory epithelium and in olfactory bulb. The finding of high levels of HO-2 mRNA by in situ hybridization prompted these studies to investigate the possibility that CO is a mediator of cGMP levels in these cells by using primary cultures of olfactory receptor neurons as an in vitro model. However, the direct measurement of CO production by HO in correlation to cGMP levels could not be made. More recent studies have supported the hypothesis that NO and CO production may be involved in LTP in the hippocampus (Schuman and Madison, 1991a; Stevens and Wang, 1993; Zhuo et al., 1993) . Although ZnPP-9 or ZnBG block the induction of LTP in the hippocampus if applied before tetanus (Stevens and Wang, 1993; Zhuo et al., 1993) and reverse established LTP when administered after tetanic stimulation (Stevens and Wang, 1993) , the role of CO in LTP has been controversial.
Some reports suggest that ZnPP-9 could be reducing LTP via NOS inhibition, because ZnPP-9 can inhibit NOS activity in hippocampal tissues (Meffert et al., 1994) . For this reason, we used the olfactory receptor neuron as a model system as it has abundant HO-2 expression but lacks neuronal NOS, making it an excellent model for the studying the role of CO. The lack of neuronal NOS has been demonstrated immunohistochemically, by Northern blot analysis, by protein immunoblot, by PCR and by catalytic assay using 3H-arginine to "H-citrulline conversion (Verma et al., 1993; Roskams et al., 1994) . Furthermore, our data herein presented indicate that 0.1 mM NAME, a potent inhibitor of NOS, fails to significantly alter cGMP levels in our olfactory receptor neuron cultures.
By immunohistochemistry, we now show at a higher resolution that HO-2 and soluble guanylyl cyclase immunoreactivities colocalize to olfactory receptor neurons, being expressed in cilia, cell bodies, and axon bundles. Similar staining patterns are obtained with two different antibodies raised against either HO-2 or soluble guanylyl cyclase. Of interest, although soluble guanylyl cyclase immunoreactivity is seen from most immature to mature olfactory receptor neurons in the epithelium, HO-2 immunoreactivity is absent from the most immature basally located olfactory receptor neurons. This suggests that HO-2 might play a role at later stages of maturation or in maturely functioning neurons competent for odorant signal transduction, whereas soluble guanylyl cyclase may havebroader functions and may be involved in signaling processes at even earlier stages of neuronal development.
To directly demonstrate that CO production mediates cGMP heme can be metabolically labeled and the production of CO directly determined. CO production is especially high in these cells, in a biological range where it could act as an activator of soluble guanylyl cyclase (l-5 FM or lo-50 pmol/mg protein). In the third days of culture, at which time cells are reextending processes and maturing, there is a peak of "CO production which essentially parallels cGMP levels. These curves may not completely overlap as YO production is measured over several hours in culture, whereas cGMP levels can be measured only at discrete time points. These experimental restraints may therefore result in some diversions in the peaks of these two activities. Taking into account endogenous glycine pools, the total level of CO produced from glycine is 100 pmol/mg protein. By using several inhibitors of HO, we demonstrate that CO production is sensitive to these inhibitors and that cGMP levels reduce with the same IC,, as for the reduction of CO production. A concern in the literature is that there is some evidence that ZnPP-9 can directly inhibit guanylyl cyclase activity in vitro (Ignarro et al., 1984) . To determine whether ZnPP-9 was acting at the level of guanylyl cyclase in cultured olfactory receptor neurons, we conducted extensive condition media transfer experiments with ZnPP-9 and ZnBG. Our data indicate that these inhibitors act at the level of HO but not at the level of guanylyl cyclase.
Nothing about neuronal regulation of HO activity has been known, but we now directly demonstrate that CO production changes dramatically during neuronal maturation. The increase in CO production and cGMP levels during the early phases of neurite outgrowth in culture, and the down-regulation of CO by TGFj32, suggest that the signaling pathway may function in phases of olfactory receptor neuron development. Recent studies show that 3H-thymidine labeling of olfactory neurons in culture peaks at 36 hr after cell plating, indicating that postmitotic neurons must develop at the end of day 2 (Calof, Chikaraishi, 1989) . This time corresponds to the maximum time of "CO release and endogenous cGMP levels in culture. The control of CO by TGF-B2 suggests that CO release is likely to occur in the steps of neuronal precursor proliferation or precursor differentiation into postmitotic neurons. During the time of neurogenesis when TGF-B2 has its effect, mediation of this effect may require CO levels to fall so that other cellular differentiation responses can be activated. TGF-B2 is known to be an olfactory neurogenic or survival factor. It can initiate terminal differentiation in olfactory receptor neurons by presumably activating TGF-B receptors on the surface of these cells. TGFj32 lowered cGMP levels to about 70% of control at day 3 when TGF-B2 clearly suppressed the peak of CO production, which supports the correlation of CO and cGMP levels. The exact role of CO in TGF-B signal transduction remains to be determined. Further elucidation of this mechanism may help further our understanding the regulation and role of CO in neuronal physiology and maturation.
